SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-21-153360
Filing Date
2021-05-06
Accepted
2021-05-06 16:33:35
Documents
8
Effectiveness Date
2021-05-06

Document Format Files

Seq Description Document Type Size
1 S-3ASR d179648ds3asr.htm S-3ASR 175539
2 EX-4.2 d179648dex42.htm EX-4.2 288557
3 EX-5.1 d179648dex51.htm EX-5.1 24274
4 EX-23.2 d179648dex232.htm EX-23.2 1430
5 GRAPHIC g179648g03z00.jpg GRAPHIC 33549
6 GRAPHIC g179648g0503222109758.jpg GRAPHIC 3252
7 GRAPHIC g179648g0503222109930.jpg GRAPHIC 1414
8 GRAPHIC g179648g20v00.jpg GRAPHIC 44120
  Complete submission text file 0001193125-21-153360.txt   596952
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

IRS No.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-255833 | Film No.: 21898412
SIC: 2834 Pharmaceutical Preparations